OPPENHEIMER GLOBAL BIO TECH FUND
485APOS, 1994-07-19
Previous: AMERICAN RICE INC, 10-Q/A, 1994-07-19
Next: MUNICIPAL INCOME OPPORTUNITIES TRUST/MA, N-30D, 1994-07-19



<PAGE>

                                                Registration No. 33-18285
                                                File No. 811-5381

                   SECURITIES AND EXCHANGE COMMISSION
                         WASHINGTON, D.C. 20549
                                FORM N-1A


REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933            / X /

     PRE-EFFECTIVE AMENDMENT NO. __                                /   /

     POST-EFFECTIVE AMENDMENT NO. 13                               / X /

                                 and/or

REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940    / X / 

     Amendment No. 15                                              / X /

                 OPPENHEIMER GLOBAL EMERGING GROWTH FUND
           (formerly named "Oppenheimer Global Bio-Tech Fund")
- -----------------------------------------------------------------------
           (Exact Name of Registrant as Specified in Charter)

          Two World Trade Center, New York, New York 10048-0203
- -----------------------------------------------------------------------
                (Address of Principal Executive Offices)

                              212-323-0200
- -----------------------------------------------------------------------
                     (Registrant's Telephone Number)

                         ANDREW J. DONOHUE, ESQ.
                   Oppenheimer Management Corporation
          Two World Trade Center, New York, New York 10048-0203
- -----------------------------------------------------------------------
                 (Name and Address of Agent for Service)

It is proposed that this filing will become effective (check appropriate
box):

     /   / Immediately upon filing pursuant to paragraph (b)

     /   / On _______________, pursuant to paragraph (b)

     /   / 60 days after filing pursuant to paragraph (a)     

     / X / On September 19, 1994, pursuant to paragraph (a)      

           of Rule 485.

- -----------------------------------------------------------------------
The Registrant has registered an indefinite number of shares under the
Securities Act of 1933 pursuant to Rule 24f-2 promulgated under the
Investment Company Act of 1940.  A Rule 24f-2 Notice for the Registrant's
fiscal year ended September 30, 1993 was filed on November 23, 1993.

<PAGE>


OPPENHEIMER GLOBAL BIO-TECH FUND




FORM N-1A - Cross Reference Sheet: Previously filed with Registrant's
Post-Effective Amendment No. 12, 7/18/94, and incorporated herein by
reference.




Part A

Prospectus and Statement of Additional Information - Oppenheimer Global
Bio-Tech Fund: Previously filed with Registrant's Post-Effective Amendment
No. 12, 7/18/94, and incorporated herein by reference.



Part B

Prospectus and Statement of Additional Information - Oppenheimer Global
Bio-Tech Fund: Previously filed with Registrant's Post-Effective Amendment
No. 12, 7/18/94, and incorporated herein by reference.



Part C

Prospectus and Statement of Additional Information - Oppenheimer Global
Bio-Tech Fund: Previously filed with Registrant's Post-Effective Amendment
No. 12, 7/18/94, and incorporated herein by reference.

<PAGE>

                               SIGNATURES

Pursuant to the requirements of the Securities Act of 1933 and/or the
Investment Company Act of 1940, the Registrant has duly caused this
Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of New York and State of New York
on the 19th day of July, 1994.

                         OPPENHEIMER GLOBAL BIO-TECH FUND

                         By: /s/ Donald W. Spiro*
                         ----------------------------------------
                         Donald W. Spiro, President
Attest:

/s/ Andrew J. Donohue*
- ----------------------------
Andrew J. Donohue, Secretary

Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed below by the following persons in
the capacities on the dates indicated:

Signatures                     Title                Date
- ----------                     -----                ----

/s/ Leon Levy*                 Chairman of the
- --------------                 Board of Trustees    July 19, 1994
Leon Levy

/s/ Donald W. Spiro*           President, Principal
- --------------------           Executive Officer
Donald W. Spiro                and Trustee          July 19, 1994

/s/ George Bowen*              Treasurer and
- -----------------              Principal Financial
George Bowen                   and Accounting
                               Officer              July 19, 1994

/s/ Leo Cherne*                Trustee              July 19, 1994
- ---------------
Leo Cherne

/s/ Edmund T. Delaney*         Trustee              July 19, 1994
- ----------------------
Edmund T. Delaney

/s/ Robert G. Galli*           Trustee              July 19, 1994
- -------------------
Robert G. Galli

/s/ Benjamin Lipstein*         Trustee              July 19, 1994
- ----------------------
Benjamin Lipstein

/s/ Kenneth A. Randall*        Trustee              July 19, 1994
- -----------------------
Kenneth A. Randall

/s/ Sidney M. Robbins*         Trustee              July 19, 1994
- ----------------------
Sidney M. Robbins

/s/ Russell S. Reynolds, Jr.*  Trustee              July 19, 1994
- -----------------------------
Russell S. Reynolds, Jr.

/s/ Pauline Trigere*           Trustee              July 19, 1994
- --------------------
Pauline Trigere

/s/ Elizabeth B. Moynihan*     Trustee              July 19, 1994
- --------------------------
Elizabeth B. Moynihan

/s/ Clayton K. Yeutter*        Trustee              July 19, 1994
- -----------------------
Clayton K. Yeutter

/s/ Edward V. Regan*           Trustee              July 19, 1994
- --------------------
Edward V. Regan


*By: /s/ Robert G. Zack
- --------------------------------
Robert G. Zack, Attorney-in-Fact




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission